CIK 0001570562 · Accelerated filer
Evolus, Inc.
Sign in to watch- Ticker
- EOLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461385614
- Phone
- (949) 284-4555
- Business address
- 520 NEWPORT CENTER DRIVE, SUITE 1200, NEWPORT BEACH, CA, 92660
- Former names
- Evolus, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $950,019
- in 1 filing
Net −$950,019. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 29 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-01-23 | MOATAZEDI DAVID See Remarks | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2019-01-23 | BLANK SIMONE Director | Grant or award · Stock Option (Right to Buy) | +14,500 | 14,500 | ||
| 2019-01-23 | Hau Bosun Director | Grant or award · Stock Option (Right to Buy) | +14,500 | 14,500 |
Page 16 of 16 · 303 trades